Publicacions en què col·labora amb Mónica de la Peña Bravo (52)

2023

  1. Hypoxic burden to guide CPAP treatment allocation in patients with obstructive sleep apnoea: a post hoc study of the ISAACC trial

    The European respiratory journal, Vol. 62, Núm. 6

  2. Proteomic profiling for prediction of recurrent cardiovascular event in patients with acute coronary syndrome and obstructive sleep apnea: A post-hoc analysis from the ISAACC study

    Biomedicine and Pharmacotherapy, Vol. 158

2022

  1. Long-Term Effect of Obstructive Sleep Apnea and Continuous Positive Airway Pressure Treatment on Blood Pressure in Patients with Acute Coronary Syndrome: A Clinical Trial

    Annals of the American Thoracic Society, Vol. 19, Núm. 10, pp. 1750-1759

  2. Respiratory Polygraphy Patterns and Risk of Recurrent Cardiovascular Events in Patients With Acute Coronary Syndrome

    Frontiers in Medicine, Vol. 9

2021

  1. Long-term Effect of CPAP Treatment on Cardiovascular Events in Patients With Resistant Hypertension and Sleep Apnea. Data From the HIPARCO-2 Study

    Archivos de Bronconeumologia, Vol. 57, Núm. 3, pp. 165-171

2020

  1. Effect of obstructive sleep apnoea and its treatment with continuous positive airway pressure on the prevalence of cardiovascular events in patients with acute coronary syndrome (ISAACC study): a randomised controlled trial

    The Lancet Respiratory Medicine, Vol. 8, Núm. 4, pp. 359-367

  2. Eficacia y coste-efectividad del diagnóstico y decisión terapéutica de la apnea obstructiva del sueño en atención primaria: descripción de la metodología.

    Revista española de patología torácica, Vol. 32, Núm. 4, pp. 260-274

  3. The effect of sleep apnea on cardiovascular events in different acute coronary syndrome phenotypes

    American Journal of Respiratory and Critical Care Medicine, Vol. 202, Núm. 12, pp. 1698-1706

2019

  1. Biomarker panel in sleep apnea patients after an acute coronary event

    Clinical Biochemistry, Vol. 68, pp. 24-29

  2. Effect of continuous positive airway pressure in patients with true refractory hypertension and sleep apnea: A post-hoc intention-to-treat analysis of the HIPARCOrandomized clinical trial

    Journal of Hypertension, Vol. 37, Núm. 6, pp. 1269-1275

  3. Factors associated with the changes from a resistant to a refractory phenotype in hypertensive patients: a Pragmatic Longitudinal Study

    Hypertension Research, Vol. 42, Núm. 11, pp. 1708-1715

  4. Good long-term adherence to continuous positive airway pressure therapy in patients with resistant hypertension and sleep apnea

    Journal of Sleep Research, Vol. 28, Núm. 5

2018

  1. Beyond resistant hypertension relationship between refractory hypertension and obstructive sleep apnea

    Hypertension, Vol. 72, Núm. 3, pp. 618-624

  2. Cardiac Troponin Values in Patients With Acute Coronary Syndrome and Sleep Apnea: A Pilot Study

    Chest, Vol. 153, Núm. 2, pp. 329-338

  3. Sleep-Disordered Breathing Is Independently Associated With Increased Aggressiveness of Cutaneous Melanoma: A Multicenter Observational Study in 443 Patients

    Chest, Vol. 154, Núm. 6, pp. 1348-1358

2017

  1. Cell death biomarkers and obstructive sleep apnea: Implications in the acute coronary syndrome

    Sleep, Vol. 40, Núm. 5

  2. Conventional polysomnography is not necessary for the management of most patients with suspected obstructive sleep apnea noninferiority, randomized controlled trial

    American Journal of Respiratory and Critical Care Medicine, Vol. 196, Núm. 9, pp. 1181-1190

2016

  1. Gut epithelial barrier markers in patients with obstructive sleep apnea

    Sleep Medicine, Vol. 26, pp. 12-15

  2. Impact of obstructive sleep apnea on the levels of placental growth factor (PlGF) and their value for predicting short-term adverse outcomes in patients with acute coronary syndrome

    PLoS ONE, Vol. 11, Núm. 3

2015

  1. Effect of obstructive sleep apnoea on severity and short-term prognosis of acute coronary syndrome

    European Respiratory Journal, Vol. 45, Núm. 2, pp. 419-427